08:32 AM EDT, 04/27/2026 (MT Newswires) -- Thermo Fisher Scientific ( TMO ) has agreed to sell its microbiology business to Astorg for about $1.08 billion, consisting of cash and a $50 million seller note, the company said Monday.

The unit provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical, and food safety applications and generated $645 million in revenue in 2025, Thermo Fisher Scientific ( TMO ) added.

The company expects the deal to reduce adjusted earnings per share by $0.15 in the first full year after closing and will update its 2026 outlook during its Q2 earnings call.